QCMS Online Seminar Series

QCMS is launching an Online Seminar Series. The inaugural session will take place on Tuesday, February 10, 2026, from 4:00 to 5:30 pm (CET).

The seminar will be held via Microsoft Teams, and the access link will be shared only with registered participants. If you are planning to attend please register here.

Further details of the lecture are provided below.

Invited Lecture 1

Reminiscing about the Future of Cheminformatics.

Alexander Tropsha

UNC Eshelman School of Pharmacy, UNC-Chapel Hill, Chapel Hill, NC, USA.

February 10, 2026 (Tuesday) 4:00pm CET.

Abstract: The field of Cheminformatics has always been one of the earliest adopters of innovations in computational data-analytical methods. Multiple algorithms leveraging fundamental advances in ML such as (deep) neural networks, multi-dimensional scaling, generative topographic mapping, support vector machines, natural language processing, generative AI and other approaches have contributed to the evolution of the field. However, one may argue that its major challenges have remained unchanged including tasks such as chemical similarity searching, QSAR modeling, molecular docking, data visualization, and rational design of new chemical entities predicted to have the desired property or activity.  Thus, the history of the field can provide hints about its future, and I will review how computational tools that address fundamental cheminformatics challenges have evolved with the major transformative component of the field: the continuing growth of biomolecular datasets including recent Big Bang expansion of synthetically feasible and purchasable Chemical Universe. These advances have created substantial computational challenges for traditional approaches to virtual screening (VS) such as similarity searching and molecular docking used in early phase drug discovery. I will describe novel resource- and cost-effective approaches to both ligand-based (LB) and structure-based (SB) VS with the focus on experimentally testable hypotheses generation. I will also discuss emerging methods for knowledge mining across multiple databases integrated into a biomedical knowledge graph to support target discovery and drug repurposing. In place of using LLM models, I will end with an attempt to hallucinate about the future of cheminformatics including greater integration of computations with experiment in self-driving labs, proliferation of cheminformatics tools and concepts across multiple disciplines, and democratization of drug discovery as part of imminent exponential growth of our field.

Speaker Profile:

Alexander Tropsha, PhD is K.H. Lee Distinguished Professor at the UNC Eshelman School of Pharmacy, and Chief Domain Scientist for Molecular Informatics at the Renaissance Computing Institute (RENCI), UNC-Chapel Hill. Prof. Tropsha obtained his PhD in Chemical Enzymology in 1986 from Moscow State University, Russia. His main research interests are in the area of Data Science with applications to drug discovery, chemical safety predictions including computational and combinatorial NAMs methods, and materials science.  He has authored or co-authored ca. 350 peer-reviewed research papers, reviews, and book chapters.  He is an elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a consultant to several technology and drug discovery companies.

Invited Lecture 2

Rethinking Bioactivity Modeling: Representation, Context, and Predictive Space

Karina Martinez Mayorga

Instituto de Quimica, UNAM, Mexico

February 10, 2026 (Tuesday) 4:45pm CET.

Abstract: Predictive models in cheminformatics are commonly built under the assumption that bioactivity varies smoothly with molecular structure, yet recent work shows that changes in experimental context, such as dose range and data distribution, can lead to abrupt losses of predictivity even when the underlying chemical space remains unchanged. This talk discusses the distinction between chemical space and predictive space, emphasizing that model performance depends on how molecular information is represented and selected rather than on structural similarity alone, and presents descriptor selection as an active step in constructing chemical space, with brief reference to alternative representations, including quantum-derived descriptors. In parallel, recent discussions on Structure–Property Associations are introduced as a complementary perspective that questions the notion of “association” itself when linking structure to biological properties, while intrinsically multidimensional response systems, such as biased agonism, are mentioned as conceptual examples highlighting broader challenges for predictive modeling in complex biological settings.

Speaker Profile:

Karina Martínez-Mayorga, PhD is a researcher in cheminformatics and computational chemical biology at the Institute of Chemistry, National Autonomous University of Mexico (UNAM). Her research focuses on predictive modeling of bioactivity, representation, and descriptor selection, with particular attention to the limitations of QSAR and machine-learning models in complex biological systems. She has published extensively in leading journals in the field and currently serves as Editor-in-Chief of the Journal of Cheminformatics.

QCMS Announces 2026 Award Recipients

2026 Hansch, Fujita and Leo Award Recipients

The QSAR, Chemoinformatics and Modeling Society (QCMS) is pleased to announce the recipients of its three biennial awards for 2026: the Hansch Award, the Fujita Award, and the Leo Award. The awardees were selected by the QCMS Board of Directors in collaboration with the International Organising Committee of 25th EuroQSAR. All awards will be formally presented at the 25th European Symposium on Quantitative Structure–Activity Relationships (EuroQSAR 2026).

Hansch Award 2026

Dr. Alpha A. Lee

The Hansch Award, established in 2000 and named after Prof. Corwin Hansch, honors a young scientist under the age of 40 for significant contributions to QSAR and related fields. The 2026 Hansch Award is presented to Dr. Alpha A. Lee in recognition of his outstanding and interdisciplinary scientific achievements.

Dr. Lee has already established an exceptional track record spanning cheminformatics, machine learning, drug discovery, and materials science. He is currently Chief Scientific Officer and co-founder of PostEra, a machine-learning–driven drug discovery company founded in 2019. He has played a leading role in open and community-driven antiviral discovery efforts, most notably as a Principal Investigator in the COVID Moonshot, which delivered a candidate targeting SARS-CoV-2 Mpro in under 18 months. He is also a Principal Investigator in the NIH-supported ASAP Discovery Consortium, which aims to establish a global pipeline of antivirals against pathogens of pandemic concern.

Dr. Lee’s scientific contributions include the development of the Molecular Transformer for chemical reaction prediction, advances in molecular and materials property prediction, and the discovery of novel antiviral compounds.

In view of his achievements and impact, Dr. Lee is widely regarded as an emerging leader in the field.


Fujita Award 2026

Prof. Dr. Tudor I. Oprea

The Fujita Award, established in 2016 in honor of Prof. Toshio Fujita, recognizes a senior scientist for sustained, influential contributions to QSAR and computational studies of biologically active compounds. The 2026 Fujita Award is presented to Prof. Dr. Tudor I. Oprea.

Prof. Oprea has made seminal contributions to cheminformatics and computer-aided drug discovery over more than three decades. He has published over 370 papers and is among the most highly cited scientists in the field. His work has shaped modern drug discovery through conceptual advances such as lead-likeness, comprehensive mapping of drug targets, and the creation of widely used open-access resources including DrugCentral and PHAROS. Importantly, his research extends beyond methodology and databases to experimentally validated compounds and clinical candidates.

Prof. Oprea has also provided long-standing service to QCMS and the EuroQSAR community. He served as Chair of the Society from 2002 to 2012 and has been a member of the EuroQSAR Scientific Advisory Committee for over two decades.

The Society is honored to recognize Prof. Oprea’s scientific leadership and service with the 2026 Fujita Award.


Leo Award 2026

Dr. Gregory Landrum

The Leo Award, established in 2026 and named after Albert J. Leo, recognizes a seminal contribution that has had a lasting, field-defining impact on QSAR and chemoinformatics. The inaugural Leo Award is presented to Dr. Gregory Landrum (ETH Zurich) for his creation and sustained leadership of RDKit.

Since its introduction in 2006, RDKit has become the most widely used open-source cheminformatics toolkit worldwide. Designed as a comprehensive and extensible platform, RDKit provides core cheminformatics algorithms, robust molecular representations, visualization tools, database integration, and seamless interoperability with modern data-science and machine-learning workflows. Its impact on academia and industry has been transformative, fundamentally changing how chemoinformatics is practiced and taught.

Beyond the software itself, Dr. Landrum has fostered a vibrant and collaborative open-source community, ensuring RDKit’s continued evolution and reliability over nearly two decades.

The scope, longevity, and influence of RDKit make Dr. Landrum’s contribution a model example of the type of achievement the Leo Award was created to honor.

QCMS Annual General Meeting 2025

On November 20th, the QSAR, Chemoinformatics and Modeling Society (QCMS) held its Annual General Meeting. The session was chaired by Prof. Rebecca Wade of the University of Heidelberg and featured the QCMS Invited Lecture delivered by Prof. Harel Weinstein, Maxwell Upson Professor of Physiology and Biophysics and Director of the Institute for Computational Biomedicine at Weill Cornell Medical College.


Prof. Weinstein presented an in-depth analysis of allosteric communication, outlining how intrinsic pathways within proteins can be identified and used to modulate function. He also discussed applications that employ AI and machine learning to investigate enzymatic and intracellular systems. The lecture offered a clear view of how quantitative approaches can support the development of new therapeutic strategies and the engineering of biological processes.


We are also pleased to announce that QCMS now has an official YouTube channel, where the full lecture is available for viewing. This platform will serve as a hub for future talks, events, and educational content.

Watch the lecture here.

Announcement: Annual General Meeting of QCMS

The Annual General Meeting (AGM) of QCMS will take place online on November 20th, 2025, at 16:00 CET.

The meeting will be held on zoom. To attend, please register by sending a short email with “AGM2025” in the subject line to info _at_ qsar.org

The meeting will open with an invited lecture by Prof. Harel Weinstein, Maxwell M. Upson Professor of Physiology and Biophysics at Cornell University.

Following the lecture, the meeting will proceed according to the standard order of business:

  • Report of activities (Scientific Director and President)
  • Financial report (past year and budget forecast)
  • Other matters

We warmly encourage all members to participate in this important annual event.

QCMS Invited Lecture 2025

Biology’s ubiquitous mechanism of allosteric communication is a designer’s ally if treated with… intelligence

It is now well established that allostery – the propagation of information over long distances at the molecular and cellular scale formalized by Monod/Changeux/Jacob – is a common and pervasive mechanism in biology. Because allosteric communication underlies function in a vast number of biomolecular systems, it is not surprising that the quest for modulators of biological function at the molecular and systems levels stumbled eventually on “allosteric modulation”. Under this name hide two different concepts: one is the modulation of the action of one ligand (the “orthosteric binder”) by another (the “allosteric binder”); the other is the modulation of the intrinsic allosteric communication that underlies the functional process itself. These two different concepts are essential, each in its own way, for enabling the design of therapeutic modalities and of various means to repair, or to mimic in engineered systems, various biological processes and molecular machines.
This presentation will focus on approaches to discover the intrinsic allosteric communication pathways in proteins, and harness their allosteric communication mechanism to modulate their functional processes. Specific applications to enzymatic and intracellular traffic machines using AI and Machine Learning approaches will illustrate such quantitative treatments of allosteric communication that generalize to address the modulation of broad spectrum of biomolecular functions.

Harel Weinstein, D.Sc. is the Maxwell Upson Professor of Physiology and Biophysics and Director of the Institute for Computational Biomedicine at Weill Cornell Medical College of Cornell University in New York City.

As a Tri-Institutional Professor, he holds professorial appointments at Rockefeller University, Sloan-Kettering Institute and Cornell University. His lab is devoted to studies in molecular and computational biophysics that address complex systems in physiology, and to the development and application of bioinformatics and AI/ML approaches to systems biology. The biomedical endpoints are signaling and neurotransmission in health and disease mechanisms, cancer, and with a recent special emphasis on translational aspects in ligand design and novel therapeutic modalities in combating infection. As the founding director of the Institute for Computational Biomedicine he has developed an academic and research unit responsible for a novel approach to biomedicine that involves the mathematical, physical, and computational sciences in combination with engineering and medical informatics, to seek a quantitative understanding of physiological function and disease, in an integrative, multi-scale approach based on gene structure and defects responsible for properties and behaviors at all levels–from protein, to cell, tissue and organ. He has received numerous honors and awards including election to Fellow of the Biophysical Society (FBPS, 2018), of the Physiological Society (FAPS, 2019), and of the American Association for the Advancement of Science (FAAAS, 2022). He served on the Executive Board of the International Society for Computational Biology and various Committees, was elected President of the Biophysical Society (2008) and served as Past President till 2011. He also served as President of the Association of Chairmen of Departments of Physiology, President of the International Society for Quantum Biology and Pharmacology, Chair of the Biophysics Section of the New York Academy of Sciences and Councilor of the Biophysical Society and of the New York Academy of Medicine.

Call for Nominations: Hansch, Fujita, and Leo Awards

QCMS is pleased to announce the Call for Nominations for the Hansch, Fujita, and Leo Awards. These awards honor outstanding contributions to the fields of quantitative structure–activity relationships (QSAR), chemoinformatics, and computational drug design.

Deadline for nominations: November 20th, 2025 (date of the 2025 General Assembly).
Following the deadline, the Award Committee will review all submissions and select the awardees.

Award winners will be invited to deliver an award lecture at the 25th EuroQSAR Symposium, which will take place in Perugia, Italy, from September 27 to October 1, 2026.

The Hansch Award (established in 2000)
Named after Prof. Corwin Hansch, father of QSAR and pioneer of physical chemistry applied to drug discovery.
Awarded to a young scientist under the age of 40
Recognizes significant contributions to QSAR and related disciplines

The Fujita Award (established in 2016)
Named after Prof. Toshio Fujita, whose pioneering work shaped QSAR and computational methods for biologically active compounds.
Awarded to a senior scientist
Recognizes a distinguished career of significant contributions in the field

The Leo Award (starting in 2026)
Named after Albert J. Leo, whose rigorous predictive tools have had a lasting impact on QSAR and chemoinformatics.
Recognizes a seminal contribution such as a theory, method, software tool, or protocol
The contribution must be innovative, widely adopted by the scientific community, and catalytic for further advances

Nomination Guidelines

Each nomination should include:

  • Full name and affiliation of the nominee
  • Award category (Hansch, Fujita, or Leo Award)
  • A brief justification explaining how the nominee’s profile and achievements align with the scope of the award
  • (Optional) Supporting materials such as a CV or list of selected publications

Submission:
Send nominations by email to info_at_qsar.org with the subject line: “Award Nomination – [Nominee’s Name]”.

25th EuroQSAR

We are glad to announce that the 25th EuroQSAR Symposium will take place in Perugia, Italy, from September 27 to October 1, 2026.

EuroQSAR Symposia have been taking place since 1973 and constitute major scientific events in computational drug design, with further applications in agricultural and environmental sciences.

The 25th EuroQSAR, entitled “Leveraging Computation for the Discovery of new Medicines”, is organised on behalf of QCMS and is chaired by Prof. Andrea Cavalli (Cecam-EPFL) and Prof. Gabriele Cruciani (University of Perugia).

The symposium will cover a wide range of topics including:

Computational Design of Covalent Drugs
Kinetics and Residence Time
Omics Science in Drug Discovery
Relative and Absolute Binding Free Energy
Drug-target Interaction via AI
QSAR and Machine Learning for DM/PK
In silico/in vitro Models for Drug Safety
Statistical Learning for Drug Discovery
Virtual Screening Successful Stories
Water in Drug Discovery
Next-generation Docking: Focus on Conformational Entropy
AI in Drug Discovery: Success or Failure
Knowledge Graph-based AI Models for Target Identification


The scientific programme will include 9 plenary lectures, 9 keynote lectures, many oral communications, company workshops, poster presentations, and a commercial exhibition.

On top, the 25th EuroQSAR will again host an Award Session, which will include the Hansch and Fujita Award Lectures. These awards are conferred by QCMS to young (Hansch) or senior (Fujita) scientists for their significant contributions to the field. The session will also include the Leo Award Lecture. This award, established in 2026, recognizes a seminal contribution in the field such as the development of a theory, method, software tool, or protocol that is innovative and widely adopted by the scientific community.

The symposium will take place in the vibrant and captivating city of Perugia, a charming hilltop city in Italy, known for its medieval streets, vibrant student life, and rich cultural heritage.

We look forward to welcoming you in Perugia in autumn 2026!

24th EuroQSAR

https://www.euroqsar.org/

Barcelona, September 22-26, 2024

The EuroQSAR Symposia have been taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

The 24th EuroQSAR Symposium, entitled “Synergizing AI and Multiscale Modeling for Drug Discovery”, is organised on behalf of QCMS and is chaired by Prof. Jordi Mestres (University of Girona, Spain)

For details and registration, see https://www.euroqsar.org/